Thursday, February 20, 2014
University of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., and Stephen Davis, M.B.B.S, the Dr. Theodore E. Woodward Professor and Chair in the Department of Medicine, have appointed renowned cardiovascular expert Sanjay Rajagopalan, M.D., F.A.C.C., F.A.H.A., to lead the newly named Division of Cardiovascular Medicine within the School’s Department of Medicine to new heights in research and patient care. The division was previously known as the Division of Cardiology.
In his new role as head of the Division of Cardiovascular Medicine at the University of Maryland, Dr. Rajagopalan has joined the leadership team of the UM Comprehensive Heart Center (CHC). The CHC has gained national recognition for bringing together multidisciplinary teams of experts to treat complex heart conditions using the latest medical, interventional and surgical techniques.
Dr. Rajagopalan, who is a widely recognized expert on the topic of environmentally induced heart disease, will be bestowed with the Melvin Sharoky Endowed Professorship in Cardiovascular Medicine at the UM School of Medicine. He was formerly the John W. Wolfe Professor of Cardiovascular Medicine at the Wexner Medical Center at the Ohio State University College of Medicine in Columbus, Ohio, and also served as the Associate Director of the Davis Heart Lung Institute there.
Dr. Rajagopalan completed clinical and research fellowships in cardiovascular medicine and vascular biology at the Emory University School of Medicine in Atlanta, Georgia, and advanced cardiovascular imaging training at Duke University in North Carolina. He has also previously served in faculty positions at the University of Michigan, Ann Arbor, and at the Mount Sinai School of Medicine in New York.
Dr. Rajagopalan’s research interests have focused on the role of inflammation in cardiometabolic disease and molecular imaging of atherosclerosis. His research is truly translational, covering the gamut of clinical to bench research. His laboratory has been continually funded over the years by the National Institutes of Health (NIH). Awards include the William Keating Award from the American College of Cardiology, and the Charles A. Dana Award, given by the Dana Foundation. Dr. Rajagopalan currently has two active RO-1 grants as primary investigator from the NIH and as part of a Center Grant from the Environmental Protection Agency (EPA) with direct costs totaling approximately $1 million/year.
Dr. Rajagopalan has published more than 200 original research publications in peer-reviewed journals such as JAMA, New England Journal of Medicine, Circulation, Journal of Clinical Investigation and Circulation Research. He has served as an editor for two textbooks, several monographs, and dozens of book chapters on vascular disease and atherosclerosis, and his research is routinely cited.
“Dr. Rajagopalan is an internationally renowned physician-scientist who has built a reputation as an investigator, with a particular interest in atherosclerosis, peripheral and vascular disease, cardiovascular MRI and CT and environmentally induced heart disease,” said Dr. Davis. “He is also a superb clinician as well as a passionate educator. We are delighted he has joined the Department of Medicine and the University of Maryland Comprehensive Heart Center. Under Dr. Rajagopalan’s leadership, I anticipate cardiovascular medicine at the University of Maryland rising to even greater heights.”
Regarding the change in the division’s name, the American Board of Internal Medicine (ABIM) certifies candidates in cardiovascular medicine, so it was logical to switch to the nomenclature that is standard among most leading U.S. academic centers. “I believe that this encompassing term more accurately reflects our collective expertise in multiple areas pertaining to the care and research of complex coronary and vascular diseases,” Dr. Davis said. “I hope that this reflects our growing sense of partnership with our surgical colleagues in vascular surgery and cardiothoracic surgery, who share our passion and joint vision for excellence in cardiovascular care at the University of Maryland.”